Gillinder Bedi1,2. Show Affiliations » 1. Department of Psychiatry, Columbia University Medical Center, New York, New York. 2. Orygen National Centre of Excellence in Youth Mental Health, University of Melbourne, Parkville, Australia.
Abstract
Entities: Chemical
Mesh： See more » Clinical Trials, Phase III as TopicCombined Modality TherapyDrug ApprovalHumansMental Disorders/drug therapyN-Methyl-3,4-methylenedioxyamphetamine/therapeutic usePsychotherapyUnited StatesUnited States Food and Drug Administration
Substances： See more » N-Methyl-3,4-methylenedioxyamphetamine
Year: 2018 PMID： 29562086 DOI： 10.1001/jamapsychiatry.2018.0063
Source DB: PubMed Journal: JAMA Psychiatry ISSN： 2168-622X Impact factor: 21.596